轻度认知障碍和神经心理学检查
1Department of Neurology, Akershus University Hospital and Department of Psychology, University of Oslo, Oslo, Norway.
Frontiers in psychology
|December 10, 2025
概括
轻度认知障碍 (MCI) 的早期诊断至关重要. 建议进行全面的神经心理评估,以准确诊断和预测MCI,帮助预防和治疗.
科学领域:
- 神经学 神经学
- 神经心理学 神经心理学
- 老年病的医生 老年病的医生
背景情况:
- 轻度认知障碍 (MCI) 影响认知功能超出正常衰老,是痴呆症的危险因素.
- MCI可能源于可治疗的医疗或心理原因,需要早期识别.
- 及时诊断允许进行干预,以防止进一步下降或管理潜在条件.
研究的目的:
- 审查MCI的诊断系统和算法.
- 突出神经心理评估在诊断MCI中的作用.
- 讨论MCI诊断和管理中的关键因素.
主要方法:
- 专注于国际上普遍存在的MCI诊断系统和算法.
- 强调神经心理评估在MCI诊断中的作用.
- 考虑认知领域,相关测试,规范和截止分数.
主要成果:
- 神经心理学评估是诊断MCI的关键.
- 讨论涵盖了相关的认知领域,测试,规范和敏感性和特异性的切断分数.
- 调查结果为神经心理评估的结论和建议提供指导.
结论:
- 对MCI进行全面的神经心理评估是推的最佳实践.
- 建议在五个认知领域 (记忆,注意力,语言,视觉空间,执行功能) 使用多个测试.
- 采用国家和文化适应的规范可以提高神经病理学和预后的有效性.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.7K
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Cognitive Development During Adulthood
745
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
745
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
